The Japanese Journal of Pharmacology · 1990 · 25 citations · 24 references
Life SciencesPharmacologyPharmacotherapyHypersensitivityInflammationPharmacodynamicsNeutrophil BiologyPhagocyte BiologyNeutrophil Effector FunctionsNeutrophil InvolvementNeutrophil MetabolismNeutrophil PhysiologyNeutrophil ReceptorsNeutrophil-mediated DamageNeutrophil-mediated Inflammation
Sites of the inhibitory action of antiallergic drugs (azelastine, oxatomide, tranilast, repirinast and amlexanox) on human neutrophils were investigated by measuring leukotriene B4 formation, arachidonic acid release and superoxide generation. Results obtained in this study were as follows: (i) Formations of leukotriene B4 by neutrophils activated with a calcium ionophore (A23187) were effectively inhibited by all types of antiallergic drugs examined here, although the required concentrations were within a range of 20-200 microM. (ii) Releases of arachidonic acid from activated cells were diminished by azelastine and oxatomide that were classified as basic antiallergic drugs. On the contrary, acidic antiallergic agents including repirinast, amlexanox and tranilast enhanced the arachidonic acid liberation. (iii) Generations of superoxide from neutrophils activated with either phorbol 12-myristate 13-acetate or n-formyl-methionyl-leucyl-phenylalanine were effectively diminished only by the basic antiallergic drugs.
24
A23187: A Divalent Cation Ionophore
Peter Reed, Henry A. Lardy · Journal of Biological Chemistry · 1972 · 1.2K citations · Full text
Leukotrienes are potent constrictors of human bronchi
Sven‐Erik Dahlén, Per Hedqvist, Sven Hammarström et al. · Nature · 1980 · 972 citations
Medicine, Pharmacology, Physiology +11